Therapeutic gene delivery is increasingly succeeding in clinical trials, and vehicles or vectors based on viruses offer the potential for safe and efficient gene transfer.
For example, the majority of the human population has been previously exposed to adeno-associated viruses (AAV), which are not associated with any disease. Vector nanoparticles based on AAV have shown positive results in... More >